Efficacy of switching therapy of luteinizing hormone–releasing hormone analogue for advanced prostate cancer

This study was conducted to determine the efficacy of switching therapy with a second-line luteinizing hormone–releasing hormone (LHRH) analogue after prostate-specific antigen (PSA) progression for advanced prostate cancer. We enrolled 200 patients, from December 2005 to September 2013, with nodal...

Full description

Bibliographic Details
Main Authors: Yuan-Chi Shen, Chih- Hsiung Kang, Po-Hui Chiang
Format: Article
Language:English
Published: Wiley 2016-11-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X16302583